B56 Regulatory Subunit of Protein Phosphatase 2A Mediates Valproic Acid-Induced p300 Degradation

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Molecular and Cellular Biology

• Publication date

  2005-01-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1128/MCB.25.2.525-532.2005PMID 15632055PMCID PMC543421
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Valproate: past, present, and future.

  2006cited by this paper
• Role of Akt/protein kinase B in the activity of transcriptional coactivator p300

  2004cited by this paper
• The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2

  2003cited by this paper
• Recruitment of p300 by C/EBPβ triggers phosphorylation of p300 and modulates coactivator activity

  2003cited by this paper
• Concomitant Increase of Histone Acetyltransferase Activity and Degradation of p300 during Retinoic Acid-induced Differentiation of F9 Cells*

  2003cited by this paper
• Polyubiquitination of p53 by a Ubiquitin Ligase Activity of p300

  2003cited by this paper
• The Transcriptional Co-activators CBP and p300 Are Activated via Phenylephrine through the p42/p44 MAPK Cascade*

  2002cited by this paper
• Attenuation of glucocorticoid signaling through targeted degradation of p300 via the 26S proteasome pathway.

  2002cited by this paper
• A proteasomal ATPase subunit recognizes the polyubiquitin degradation signal

  2002cited by this paper
• B56-Associated Protein Phosphatase 2A Is Required For Survival and Protects from Apoptosis in Drosophila melanogaster

  2002cited by this paper
• Growth suppression of human carcinoma cells by reintroduction of the p300 coactivator

  2002cited by this paper
• Regulation of Jak2 through the Ubiquitin-Proteasome Pathway Involves Phosphorylation of Jak2 on Y1007 and Interaction with SOCS-1

  2002cited by this paper
• From natural disability to the moral man: Calvinism and the history of psychology

  2001cited by this paper
• Transcription coactivator p300 binds PCNA and may have a role in DNA repair synthesis

  2001cited by this paper
• Stimulation of p300-mediated Transcription by the Kinase MEKK1*

  2001cited by this paper
• Histone Deacetylase Is a Direct Target of Valproic Acid, a Potent Anticonvulsant, Mood Stabilizer, and Teratogen*

  2001cited by this paper
• Regulation of Transcriptional Activation Domain Function by Ubiquitin

  2001cited by this paper
• Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells

  2001cited by this paper
• The 26S Proteasome Is Required for Estrogen Receptor-α and Coactivator Turnover and for Efficient Estrogen Receptor-α Transactivation

  2000cited by this paper
• Phosphorylation of p300 at Serine 89 by Protein Kinase C*

  2000cited by this paper
• A truncated isoform of the PP2A B56 subunit promotes cell motility through paxillin phosphorylation

  2000cited by this paper
• CBP/p300 in cell growth, transformation, and development.

  2000cited by this paper
• Orchestrated response: a symphony of transcription factors for gene control.

  2000cited by this paper
• The hPLIC proteins may provide a link between the ubiquitination machinery and the proteasome.

  2000cited by this paper
• The 26S proteasome is required for estrogen receptor-alpha and coactivator turnover and for efficient estrogen receptor-alpha transactivation.

  2000cited by this paper
• Posttranslational Modification of Bcl-2 Facilitates Its Proteasome-Dependent Degradation: Molecular Characterization of the Involved Signaling Pathway

  2000cited by this paper
• Proteasome-Mediated Degradation of the Coactivator p300 Impairs Cardiac Transcription

  2000cited by this paper
• Protein phosphatase 2A: a panoply of enzymes.

  2000cited by this paper
• Fundamentally different logic of gene regulation in eukaryotes and prokaryotes.

  1999cited by this paper
• Regulation of beta-catenin signaling by the B56 subunit of protein phosphatase 2A.

  1999cited by this paper
• Proteasome‐mediated degradation of transcriptional activators correlates with activation domain potency in vivo

  1999cited by this paper
• Regulation of β-Catenin Signaling by the B56 Subunit of Protein Phosphatase 2A

  1999cited by this paper
• Valproate: a reappraisal of its pharmacodynamic properties and mechanisms of action.

  1999cited by this paper
• p300 stimulates transcription instigated by ligand‐bound thyroid hormone receptor at a step subsequent to chromatin disruption

  1999cited by this paper
• The ubiquitin–proteasome pathway: on protein death and cell life

  1998cited by this paper
• Proteasome inhibitors: valuable new tools for cell biologists.

  1998influential reference
• Gene dosage-dependent embryonic development and proliferation defects in mice lacking the transcriptional integrator p300.

  1998influential reference
• Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation

  1998cited by this paper
• Xenopus NF‐Y pre‐sets chromatin to potentiate p300 and acetylation‐responsive transcription from the Xenopus hsp70 promoter in vivo

  1998cited by this paper
• Reduced Ubiquitin-Dependent Degradation of c-Jun After Phosphorylation by MAP Kinases

  1997cited by this paper
• The Effects of Sodium Butyrate on Transcription Are Mediated through Activation of a Protein Phosphatase*

  1997cited by this paper
• Identification of a Novel Protein Phosphatase 2A Regulatory Subunit Highly Expressed in Muscle (*)

  1996cited by this paper
• The transcriptional coactivators p300 and CBP are histone acetyltransferases.

  1996cited by this paper
• Role of CBP/P300 in nuclear receptor signalling

  1996cited by this paper
• The SV40 large T antigen and adenovirus E1a oncoproteins interact with distinct isoforms of the transcriptional co‐activator, p300.

  1996cited by this paper
• The B56 Family of Protein Phosphatase 2A (PP2A) Regulatory Subunits Encodes Differentiation-induced Phosphoproteins That Target PP2A to Both Nucleus and Cytoplasm*

  1996cited by this paper
• Phosphorylation of the adenovirus E1A‐associated 300 kDa protein in response to retinoic acid and E1A during the differentiation of F9 cells.

  1995cited by this paper
• A novel pathway for vitamin A signaling mediated by RXR heterodimerization with NGFI-B and NURR1.

  1995cited by this paper
• Identification of a New Family of Protein Phosphatase 2A Regulatory Subunits (*)

  1995cited by this paper
• Signal-induced site-specific phosphorylation targets I kappa B alpha to the ubiquitin-proteasome pathway.

  1995cited by this paper
• Molecular cloning and functional analysis of the adenovirus E1A-associated 300-kD protein (p300) reveals a protein with properties of a transcriptional adaptor.

  1994cited by this paper
• Analysis with specific polyclonal antiserum indicates that the E1A-associated 300-kDa product is a stable nuclear phosphoprotein that undergoes cell cycle phase-specific modification

  1991cited by this paper
• Valproic acid-induced neural tube defects in mouse and human: aspects of chirality, alternative drug development, pharmacokinetics and possible mechanisms.

  1991cited by this paper
• Okadaic acid: a new probe for the study of cellular regulation.

  1990cited by this paper
• Butyrate and related inhibitors of histone deacetylation block the induction of egg white genes by steroid hormones.

  1980cited by this paper

• Ubiquitin proteasome system (UPS): a crucial determinant of the epigenetic landscape in cancer.

  2025cites this paper
• Beyond epilepsy: The expanding role of valproic acid in Alzheimer disease therapy - a review.

  2025cites this paper
• p300 nucleocytoplasmic shuttling underlies mTORC1 hyperactivation in Hutchinson–Gilford progeria syndrome

  2024cites this paper
• Regulation and role of the PP2A-B56 holoenzyme family in cancer.

  2023cites this paper
• Regulation of Dystroglycan Gene Expression in Early Myoblast Differentiation

  2022cites this paper
• Valproic acid restricts mast cell activation by Listeria monocytogenes

  2022cites this paper
• Dissecting myogenin-mediated retinoid X receptor signaling in myogenic differentiation

  2020cites this paper
• Dissecting myogenin-mediated retinoid X receptor signaling in myogenic differentiation

  2020cites this paper
• Loci-specific histone acetylation profiles associated with transcriptional coactivator p300 during early myoblast differentiation

  2018cites this paper
• Insights into interplay between rexinoid signaling and myogenic regulatory factor-associated chromatin state in myogenic differentiation

  2017cites this paper
• Valproic acid increases NF-κB transcriptional activation despite decreasing DNA binding ability in P19 cells, which may play a role in VPA-initiated teratogenesis.

  2017cites this paper
• EXAMINATION OF THE EFFECTS OF VALPROIC ACID EXPOSURE OR P300 PROTEIN INHIBITION ON THE BALANCE OF APOPTOSIS AND PROLIFERATION IN P19 EMBRYONAL CARCINOMA CELLS

  2016influential citation
• Valproic acid exposure decreases Cbp/p300 protein expression and histone acetyltransferase activity in P19 cells.

  2016influential citation
• Implication of retinoic acid receptor selective signaling in myogenic differentiation

  2016cites this paper
• Trichostatin A, a histone deacetylase inhibitor suppresses NADPH Oxidase 4‐Derived Redox Signalling and Angiogenesis

  2016cites this paper
• Molecular Basis for the Regulation of Transcriptional Coactivator p300 in Myogenic Differentiation

  2015cites this paper
• Retinoid X Receptor-selective Signaling in the Regulation of Akt/Protein Kinase B Isoform-specific Expression*

  2015cites this paper
• Identification of distinct macrophage subpopulations during nitrogen mustard-induced lung injury and fibrosis: mechanisms of recruitment and activation

  2015influential citation
• Activation of GATA4 gene expression at the early stage of cardiac specification

  2014cites this paper
• Regulation of histone modifying enzymes by the ubiquitin-proteasome system.

  2014cites this paper
• Targeting PP2A activation as a novel therapeutic strategy for receptor tyrosine kinase driven leukaemia

  2014cites this paper
• Cooperation of p300 and iASPP in apoptosis and tumour suppression

  2014cites this paper
• B56γ Tumor-Associated Mutations Provide New Mechanisms for B56γ-PP2A Tumor Suppressor Activity

  2013cites this paper
• A Tumor Suppressor Activity γ B 56 Tumor-Associated Mutations Provide New Mechanisms for γ B 56

  2013cites this paper
• Use of histone deacetylase inhibitors to examine the roles of bromodomain and histone acetylation in p300-dependent gene expression.

  2013cites this paper
• Induction of Pax3 gene expression impedes cardiac differentiation

  2013cites this paper
• Stepwise acetyltransferase association and histone acetylation at the Myod1 locus during myogenic differentiation

  2013cites this paper
• Characterization of Tumor-Derived B56gamma Mutations and Their Effect on Tumor Suppressor Function of B56gamma PP2A

  2013cites this paper
• Regulation of Myf5 Early Enhancer by Histone Acetyltransferase p300 during Stem Cell Differentiation

  2012cites this paper
• Life and death of transcriptional co-activator p300

  2011cites this paper
• Contribution of Retinoid X Receptor Signaling to the Specification of Skeletal Muscle Lineage*

  2011cites this paper
• Promoter context determines the role of proteasome in ligand-dependent occupancy of retinoic acid responsive elements

  2011cites this paper
• Interplay of bromodomain and histone acetylation in the regulation of p300-dependent genes

  2010cites this paper
• Intracellular distribution of p300 and its differential recruitment to aggresomes in breast cancer.

  2010cites this paper
• A tumor suppressor role for PP2A-B56α through negative regulation of c-Myc and other key oncoproteins

  2008cites this paper
• Structural Studies on PP2A and Methods in Protein Production

  2008cites this paper
• PML Activates Transcription by Protecting HIPK2 and p300 from SCFFbx3-Mediated Degradation

  2008cites this paper
• Involvement of PML nuclear bodies in CBP degradation through the ubiquitin-proteasome pathway

  2008cites this paper
• Inhibition of B56-containing Protein Phosphatase 2As by the Early Response Gene IEX-1 Leads to Control of Akt Activity*

  2007cites this paper
• The use of RNA interference to analyze protein phosphatase function in mammalian cells.

  2007cites this paper
• Ubiquitin-Dependent Distribution of the Transcriptional Coactivator p300 in Cytoplasmic Inclusion Bodies

  2007cites this paper
• Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 ( NR 5 A 1 )

  2007cites this paper
• Histone Deacetylase Inhibitors Reduce Steroidogenesis through SCF-Mediated Ubiquitination and Degradation of Steroidogenic Factor 1 (NR5A1)

  2007cites this paper
• B56‐containing PP2A dephosphorylate ERK and their activity is controlled by the early gene IEX‐1 and ERK

  2006cites this paper
• Conditional Knockout Mice Reveal Distinct Functions for the Global Transcriptional Coactivators CBP and p300 in T-Cell Development

  2006cites this paper
• Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B

  2006cites this paper
• Protein Phosphatase 2A Regulatory Subunit B56α Associates with c-Myc and Negatively Regulates c-Myc Accumulation

  2006cites this paper